成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Rimcazole

Rimcazole Struktur
75859-04-0
CAS-Nr.
75859-04-0
Englisch Name:
Rimcazole
Synonyma:
Rimcazol;Rimcazolum;Rimcazole [inn];Rimcazol [inn-spanish];Rimcazolum [inn-latin];9-[3-(3β,5β-Dimethylpiperazino)propyl]-9H-carbazole;9-[3-(3α,5α-Dimethyl-1-piperazinyl)propyl]-9H-carbazole;9-[3-[(3S,5R)-3,5-dimethylpiperazin-1-yl]propyl]carbazole;9H-Carbazole, 9-(3-(3,5-dimethyl-1-piperazinyl)propyl)-, cis-;(3R)-1-[3-(9H-Carbazole-9-yl)propyl]-3β,5β-dimethylpiperazine
CBNumber:
CB71179663
Summenformel:
C21H27N3
Molgewicht:
321.46
MOL-Datei:
75859-04-0.mol

Rimcazole Eigenschaften

Siedepunkt:
499.1±45.0 °C(Predicted)
Dichte
1.14±0.1 g/cm3(Predicted)
pka
9.32±0.60(Predicted)

Sicherheit

Rimcazole Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Antipsychotic.

Rimcazole Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Rimcazole Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 32161 58
TargetMol Chemicals Inc.
+8613564774135
zijue.cai@tsbiochem.com United States 19885 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9806 58
Changzhou Furuisi Biotechnology Co., Ltd 0519-85524369
3477467573@qq.com China 8617 58
TargetMol Chemicals Inc. 15002134094
marketing@targetmol.cn China 19704 58

  • Rimcazolum [inn-latin]
  • Rimcazolum
  • Rimcazole [inn]
  • Rimcazol [inn-spanish]
  • Rimcazol
  • 9H-Carbazole, 9-(3-(3,5-dimethyl-1-piperazinyl)propyl)-, cis-
  • 9-[3-(3β,5β-Dimethylpiperazino)propyl]-9H-carbazole
  • 9-[3-(3α,5α-Dimethyl-1-piperazinyl)propyl]-9H-carbazole
  • (3R)-1-[3-(9H-Carbazole-9-yl)propyl]-3β,5β-dimethylpiperazine
  • 9H-Carbazole, 9-[3-[(3R,5S)-3,5-dimethyl-1-piperazinyl]propyl]-, rel-
  • 9-[3-[(3S,5R)-3,5-dimethylpiperazin-1-yl]propyl]carbazole
  • 75859-04-0
Copyright 2019 ? ChemicalBook. All rights reserved